MedTrace Logo

Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse

NCT02188589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-03-26

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and feasibility of the INEX Nasal Implant in subjects with moderate to severe nasal valve collapse.

Conditions

  • Nasal Valve Collapse

Interventions

DEVICE

INEX nasal implant

Treatment group may receive unilateral or bilateral INEX nasal implants (maximum of 4, 2 per side)

Sponsors & Collaborators

  • Spirox, Inc.

    lead INDUSTRY

Principal Investigators

  • Alexander Berghaus, MD · Ludwig-Maximilians - University of Munich

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-12-31
Completion
2017-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02188589 on ClinicalTrials.gov